Uncharacterized Protein, Uncharacterized
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4IDL4
Term | Name | Level | Count |
---|---|---|---|
GO:0005488 | binding | 1 | 5 |
GO:0005509 | calcium ion binding | 5 | 5 |
GO:0043167 | ion binding | 2 | 5 |
GO:0043169 | cation binding | 3 | 5 |
GO:0046872 | metal ion binding | 4 | 5 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 144 | 146 | PF00675 | 0.545 |
CLV_NRD_NRD_1 | 293 | 295 | PF00675 | 0.541 |
CLV_PCSK_KEX2_1 | 144 | 146 | PF00082 | 0.545 |
CLV_PCSK_KEX2_1 | 32 | 34 | PF00082 | 0.553 |
CLV_PCSK_PC1ET2_1 | 32 | 34 | PF00082 | 0.396 |
CLV_PCSK_SKI1_1 | 119 | 123 | PF00082 | 0.436 |
CLV_PCSK_SKI1_1 | 172 | 176 | PF00082 | 0.394 |
CLV_PCSK_SKI1_1 | 179 | 183 | PF00082 | 0.341 |
DEG_APCC_DBOX_1 | 239 | 247 | PF00400 | 0.396 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.414 |
DOC_MAPK_FxFP_2 | 195 | 198 | PF00069 | 0.313 |
DOC_PP2B_LxvP_1 | 324 | 327 | PF13499 | 0.492 |
DOC_PP4_FxxP_1 | 195 | 198 | PF00568 | 0.313 |
DOC_USP7_MATH_1 | 13 | 17 | PF00917 | 0.362 |
DOC_USP7_MATH_1 | 154 | 158 | PF00917 | 0.593 |
DOC_USP7_MATH_1 | 327 | 331 | PF00917 | 0.579 |
DOC_USP7_UBL2_3 | 319 | 323 | PF12436 | 0.531 |
DOC_WW_Pin1_4 | 147 | 152 | PF00397 | 0.624 |
LIG_14-3-3_CanoR_1 | 263 | 268 | PF00244 | 0.450 |
LIG_BIR_III_2 | 148 | 152 | PF00653 | 0.516 |
LIG_BRCT_BRCA1_1 | 69 | 73 | PF00533 | 0.373 |
LIG_Clathr_ClatBox_1 | 139 | 143 | PF01394 | 0.415 |
LIG_CtBP_PxDLS_1 | 198 | 202 | PF00389 | 0.389 |
LIG_FHA_1 | 20 | 26 | PF00498 | 0.473 |
LIG_FHA_2 | 181 | 187 | PF00498 | 0.339 |
LIG_FHA_2 | 237 | 243 | PF00498 | 0.373 |
LIG_FHA_2 | 70 | 76 | PF00498 | 0.473 |
LIG_Integrin_RGD_1 | 184 | 186 | PF01839 | 0.345 |
LIG_LIR_Apic_2 | 207 | 211 | PF02991 | 0.481 |
LIG_LIR_Gen_1 | 70 | 79 | PF02991 | 0.473 |
LIG_LIR_Nem_3 | 129 | 134 | PF02991 | 0.336 |
LIG_LIR_Nem_3 | 227 | 233 | PF02991 | 0.350 |
LIG_LIR_Nem_3 | 70 | 76 | PF02991 | 0.473 |
LIG_PTB_Apo_2 | 272 | 279 | PF02174 | 0.441 |
LIG_PTB_Phospho_1 | 272 | 278 | PF10480 | 0.439 |
LIG_SH2_CRK | 313 | 317 | PF00017 | 0.511 |
LIG_SH2_PTP2 | 208 | 211 | PF00017 | 0.414 |
LIG_SH2_SRC | 88 | 91 | PF00017 | 0.463 |
LIG_SH2_STAP1 | 132 | 136 | PF00017 | 0.351 |
LIG_SH2_STAP1 | 219 | 223 | PF00017 | 0.410 |
LIG_SH2_STAP1 | 88 | 92 | PF00017 | 0.530 |
LIG_SH2_STAT3 | 309 | 312 | PF00017 | 0.550 |
LIG_SH2_STAT5 | 194 | 197 | PF00017 | 0.428 |
LIG_SH2_STAT5 | 208 | 211 | PF00017 | 0.482 |
LIG_SH2_STAT5 | 230 | 233 | PF00017 | 0.404 |
LIG_SH2_STAT5 | 320 | 323 | PF00017 | 0.616 |
LIG_SH2_STAT5 | 34 | 37 | PF00017 | 0.456 |
LIG_SH3_3 | 109 | 115 | PF00018 | 0.426 |
LIG_SH3_3 | 117 | 123 | PF00018 | 0.397 |
LIG_SH3_3 | 174 | 180 | PF00018 | 0.296 |
LIG_SUMO_SIM_par_1 | 22 | 29 | PF11976 | 0.462 |
LIG_UBA3_1 | 168 | 175 | PF00899 | 0.444 |
LIG_UBA3_1 | 273 | 280 | PF00899 | 0.409 |
LIG_WRC_WIRS_1 | 301 | 306 | PF05994 | 0.541 |
MOD_CK1_1 | 150 | 156 | PF00069 | 0.600 |
MOD_CK1_1 | 157 | 163 | PF00069 | 0.540 |
MOD_CK1_1 | 262 | 268 | PF00069 | 0.522 |
MOD_CK2_1 | 69 | 75 | PF00069 | 0.450 |
MOD_GlcNHglycan | 152 | 155 | PF01048 | 0.727 |
MOD_GlcNHglycan | 159 | 162 | PF01048 | 0.632 |
MOD_GlcNHglycan | 199 | 204 | PF01048 | 0.362 |
MOD_GlcNHglycan | 282 | 285 | PF01048 | 0.499 |
MOD_GlcNHglycan | 329 | 332 | PF01048 | 0.475 |
MOD_GlcNHglycan | 49 | 52 | PF01048 | 0.419 |
MOD_GSK3_1 | 122 | 129 | PF00069 | 0.356 |
MOD_GSK3_1 | 150 | 157 | PF00069 | 0.669 |
MOD_GSK3_1 | 219 | 226 | PF00069 | 0.321 |
MOD_GSK3_1 | 259 | 266 | PF00069 | 0.402 |
MOD_GSK3_1 | 327 | 334 | PF00069 | 0.490 |
MOD_GSK3_1 | 43 | 50 | PF00069 | 0.551 |
MOD_LATS_1 | 298 | 304 | PF00433 | 0.465 |
MOD_N-GLC_1 | 19 | 24 | PF02516 | 0.413 |
MOD_PIKK_1 | 122 | 128 | PF00454 | 0.358 |
MOD_PKA_1 | 279 | 285 | PF00069 | 0.475 |
MOD_PKA_2 | 211 | 217 | PF00069 | 0.453 |
MOD_PKA_2 | 262 | 268 | PF00069 | 0.427 |
MOD_PKA_2 | 52 | 58 | PF00069 | 0.474 |
MOD_Plk_1 | 219 | 225 | PF00069 | 0.355 |
MOD_Plk_1 | 99 | 105 | PF00069 | 0.413 |
MOD_Plk_4 | 132 | 138 | PF00069 | 0.340 |
MOD_Plk_4 | 263 | 269 | PF00069 | 0.483 |
MOD_Plk_4 | 99 | 105 | PF00069 | 0.440 |
MOD_ProDKin_1 | 147 | 153 | PF00069 | 0.629 |
TRG_ENDOCYTIC_2 | 230 | 233 | PF00928 | 0.321 |
TRG_ENDOCYTIC_2 | 313 | 316 | PF00928 | 0.505 |
TRG_Pf-PMV_PEXEL_1 | 172 | 176 | PF00026 | 0.321 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PBZ0 | Leptomonas seymouri | 72% | 98% |
A0A1X0NFQ9 | Trypanosomatidae | 43% | 100% |
A0A3Q8IH99 | Leishmania donovani | 99% | 100% |
A0A3R7N4F8 | Trypanosoma rangeli | 43% | 100% |
A4HPA6 | Leishmania braziliensis | 82% | 100% |
D0A3B4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 41% | 100% |
E9AT17 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 94% | 100% |
Q4Q1I1 | Leishmania major | 96% | 100% |